Comparison of Efficacy and Safety Outcomes of Different Doses Schedules of Thalidomide for Treating Moderate-to-Severe β-Thalassemia Patients
Wei-Jia Yang,1,* Lian-dong Shi,2,* Ye Liang,3,* Li-ming Liang,4,* Hao Zhang,5 Li Wang,2 Qian Zhou1 1Department of Eugenics and Genetics, Guilin People’s Hospital, Guilin, Guangxi Zhuang Autonomous Region, 541002, People’s Republic of China; 2Department of Ultrasound,...
Saved in:
| Main Authors: | Yang WJ, Shi LD, Liang Y, Liang LM, Zhang H, Wang L, Zhou Q |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2024-11-01
|
| Series: | Therapeutics and Clinical Risk Management |
| Subjects: | |
| Online Access: | https://www.dovepress.com/comparison-of-efficacy-and-safety-outcomes-of-different-doses-schedule-peer-reviewed-fulltext-article-TCRM |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THALIDOMIDE FOR PATIENTS WITH THALASSEMIA INTERMEDIA: A RETROSPECTIVE MULTICENTER CLINICAL STUDY
by: Kun Yang, et al.
Published: (2020-04-01) -
Biochemical Status of Beta-Thalassemia Major Patients in Erbil City
by: Omar Surchi, et al.
Published: (2018-06-01) -
A Triple Therapeutic Regiment Consisted of Colchicine, Thalidomide and Total Glucosides of Paeony Is Effective and Well‐Tolerated for Treating Mucocutaneous Involvement in Patients With Behcet's Disease
by: Jian‐Fei Cai, et al.
Published: (2024-12-01) -
Therapeutic failure with thalidomide in patients with recurrent intestinal bleeding due to angiodysplasias
by: María del Carmen Izquierdo Navarro, et al.
Published: (2016-05-01) -
Bortezomib, thalidomide, and dexamethasone versus thalidomide and dexamethasone for response rates in multiple myeloma patients: a retrospective study
by: Juan M. Cano-Calderón, et al.
Published: (2025-01-01)